Aurora Cannabis Inc. (ACB) vs Indaptus Therapeutics, Inc. (INDP)

A side-by-side comparison of Aurora Cannabis Inc. and Indaptus Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACB vs INDP

growth of $100 · dividends reinvested · last 10y
ACB -97.3% (-30.2%/yr)INDP -100.0% (-57.5%/yr)ACB compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $10020182020202220242026$3$0
ACB INDP

ACB vs INDP: by the numbers

  • •INDP is the larger company ($293M vs $284M market cap).
  • •Both run net losses; INDP's is the smaller (0.00% vs -38.13% net margin).

Metrics side by side

Valuation

MetricACBINDP
P/S ratio1.36N/A
P/B ratio0.7725.79

Profitability

MetricACBINDP
Gross margin42.62%0.00%
Operating margin-14.55%0.00%
Net margin-38.13%0.00%
ROE-21.41%-135.62%
ROIC-15.69%-129.90%

Growth (annualized)

MetricACBINDP
Revenue CAGR (5Y)1.68%N/A
Total return CAGR (5Y)-42.83%-58.32%

Frequently asked

How have ACB and INDP total returns compared?
Over the past 10 years, ACB delivered -30.23% and INDP delivered -57.48% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.